Search research articles
Contact Us
Filters
Showing results (31-40 of 85) with videos related to
Page
of 9
Sort By:
Experimental Dermatology
|
May 21, 2010
Reduction of different inflammatory cell types of the innate immune system in psoriatic skin during etanercept treatment
Marjan de Groot, Marcel B M Teunissen, Daisy I Picavet, et al.
The Journal of Dermatology
|
April 2, 2011
Validation and refinement of the Millennium Criteria for atopic dermatitis
Mandy E Schram, Mariska M G Leeflang, Jan Paul S DEN Ottolander, et al.
Archives of Dermatology
|
October 20, 2004
Analysis of risk factors in psoriatic patients with methotrexate-induced increases in transaminase levels
Vera M R Heydendael, Phyllis I Spuls, Patrick M M Bossuyt, et al.
Dermatology (Basel, Switzerland)
|
February 9, 2002
Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis
Edwin J M Van Leent, Marie Eve Ebelin, Pascale Burtin, et al.
Photochemistry and Photobiology
|
September 2, 2004
Suppression of different phases of systemic contact hypersensitivity by urocanic acid oxidation products
Arthur Kammeyer, Johan Garssen, Annemarie Sleijffers, et al.
Contact Dermatitis
|
October 10, 2013
Wet work and hand eczema in apprentice nurses; part I of a prospective cohort study
Maaike J Visser, Maarten M Verberk, Frank J H van Dijk, et al.
Journal of the American Academy of Dermatology
|
February 19, 2008
Clinical differences between atopic and atopiform dermatitis
Elian E A Brenninkmeijer, Phyllis I Spuls, Catharina M Legierse, et al.
The Journal of Dermatological Treatment
|
March 17, 2007
Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 year
Edwin J M Van Leent, Henry J C De Vries, Marie-Eve Ebelin, et al.
The Journal of Investigative Dermatology
|
January 1, 2010
How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review
Phyllis I Spuls, Lidian L A Lecluse, Marie-Louise N F Poulsen, et al.
Journal of Telemedicine and Telecare
|
October 6, 2010
A pilot study on tertiary teledermatology: feasibility and acceptance of telecommunication among dermatologists
Job P van der Heijden, Nicolet F de Keizer, Frans P Voorbraak, et al.
Page
of 9
Search research articles
Search
Showing results (31-40 of 85) with videos related to
Sort By:
Page
of 9
Experimental Dermatology
|
May 21, 2010
Reduction of different inflammatory cell types of the innate immune system in psoriatic skin during etanercept treatment
Marjan de Groot, Marcel B M Teunissen, Daisy I Picavet, et al.
The Journal of Dermatology
|
April 2, 2011
Validation and refinement of the Millennium Criteria for atopic dermatitis
Mandy E Schram, Mariska M G Leeflang, Jan Paul S DEN Ottolander, et al.
Archives of Dermatology
|
October 20, 2004
Analysis of risk factors in psoriatic patients with methotrexate-induced increases in transaminase levels
Vera M R Heydendael, Phyllis I Spuls, Patrick M M Bossuyt, et al.
Dermatology (Basel, Switzerland)
|
February 9, 2002
Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis
Edwin J M Van Leent, Marie Eve Ebelin, Pascale Burtin, et al.
Photochemistry and Photobiology
|
September 2, 2004
Suppression of different phases of systemic contact hypersensitivity by urocanic acid oxidation products
Arthur Kammeyer, Johan Garssen, Annemarie Sleijffers, et al.
Contact Dermatitis
|
October 10, 2013
Wet work and hand eczema in apprentice nurses; part I of a prospective cohort study
Maaike J Visser, Maarten M Verberk, Frank J H van Dijk, et al.
Journal of the American Academy of Dermatology
|
February 19, 2008
Clinical differences between atopic and atopiform dermatitis
Elian E A Brenninkmeijer, Phyllis I Spuls, Catharina M Legierse, et al.
The Journal of Dermatological Treatment
|
March 17, 2007
Blood concentrations of pimecrolimus in adult patients with atopic dermatitis following intermittent administration of pimecrolimus cream 1% (Elidel) for up to 1 year
Edwin J M Van Leent, Henry J C De Vries, Marie-Eve Ebelin, et al.
The Journal of Investigative Dermatology
|
January 1, 2010
How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review
Phyllis I Spuls, Lidian L A Lecluse, Marie-Louise N F Poulsen, et al.
Journal of Telemedicine and Telecare
|
October 6, 2010
A pilot study on tertiary teledermatology: feasibility and acceptance of telecommunication among dermatologists
Job P van der Heijden, Nicolet F de Keizer, Frans P Voorbraak, et al.
Page
of 9